MONOCLONAL ANTIBODIES IN CANCER TREATMENT
- 15 March 1986
- journal article
- Published by Elsevier in The Lancet
- Vol. 327 (8481) , 603-605
- https://doi.org/10.1016/s0140-6736(86)92821-7
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Imaging of primary and metastatic colorectal cancer using an 111In-labelled antitumour monoclonal antibody (791T/36)Nuclear Medicine Communications, 1985
- Antitumor properties of vindesine-monoclonal antibody conjugatesCancer Immunology, Immunotherapy, 1985
- The localization of human breast carcinomas by radiolabelled monoclonal antibodiesBritish Journal of Surgery, 1984
- ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)The Lancet, 1984
- Ovarian cancerNuclear Medicine Communications, 1984
- Preparation of four daunomycin‐monoclonal antibody 79IT/36 conjugates with anti‐tumour activityInternational Journal of Cancer, 1984
- Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.Journal of Clinical Investigation, 1983
- Allogenic bone marrow transplantation: current status and future directionsBlood, 1983
- Preparation and properties of a drug‐carrier‐antibody conjugate showing selective antibody‐directed cytotoxicity in vitroInternational Journal of Cancer, 1983
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975